ODI Pharma AB (6OD) Stock Statistics & Valuation Metrics

ODI Pharma AB has a market cap or net worth of EUR 3.60M. The enterprise value is EUR 5.74M.

Market Cap

EUR 3.60M

Enterprise Value

EUR 5.74M

ODI Pharma AB has 18,330,420 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

18,330,420

Owned by Insiders

―

Owned by Institutions

―

ODI Pharma AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

-3.63M

Employee Count

1

Asset Turnover

―

Inventory Turnover

―

In the last 12 months, ODI Pharma AB had revenue of ― and earned -3.63M in profits. Earnings per share was ―.

Revenue

―

Gross Profit

―

Operating Income

-3.34M

Pretax Income

―

Net Income

-3.63M

EBITDA

-3.34M

Earnings Per Share (EPS)

―

Beta

0.91

52-Week Price Change

125.00%

50-Day Moving Average

0.14

200-Day Moving Average

0.24

Relative Strength Index (RSI)

67.73

Average Volume (3m)

―

ODI Pharma AB upcoming earnings date is Nov 20, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 27, 2026

Next Earnings Date

Nov 20, 2026

Ex-Dividend Date

―

ODI Pharma AB has ― in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

EUR 0.00

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

The average price target for ODI Pharma AB is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

999.82%

EPS Growth Forecast

―